MARKET

POAI

POAI

Predictive Oncology Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9539
-0.0961
-9.15%
Pre Market: 0.9756 +0.0217 +2.27% 07:34 04/21 EDT
OPEN
1.030
PREV CLOSE
1.050
HIGH
1.040
LOW
0.9275
VOLUME
1.55K
TURNOVER
--
52 WEEK HIGH
2.300
52 WEEK LOW
0.6300
MARKET CAP
46.54M
P/E (TTM)
-0.4000
1D
5D
1M
3M
1Y
5Y
Predictive Oncology's (NASDAQ: POAI) Subsidiary Refining, Strengthening Personalized Oncology Approach to Ovarian Cancer
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of female reproductive system TumorGenesis can...
Investor Brand Network · 1d ago
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market
Apr 16, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity...
Investor Brand Network · 4d ago
Study Finds That Sugar Compromises Brain Development in Children
Apr 14, 2021 (Investor Brand Network via COMTEX) -- A recent study conducted by a faculty member from the University of Georgia, in partnership with a team...
Investor Brand Network · 6d ago
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expansion of AI-Driven Clinical Models
Investor Brand Network · 04/09 16:23
FUBO, TXMD among premarket gainers
Celcuity (CELC) +55% on licensing agreement up to $340M for breast cancer treatment gedatolisib.Affimed N.V. (AFMD) +29% on positive data from NK cells + AFM13 in solid tumors.Greenwich LifeSciences (GLSI) +29% on robust
Seekingalpha · 04/09 12:33
Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO
Current POAI Chairman J. Melville ("Mel") Engle has been appointed to CEO position Engle has held executive positions throughout his career at leading pharma...
Investor Brand Network · 04/05 17:31
ACAD, NNOX, CTRM and DMYD among midday movers
Gainers: Chembio Diagnostics (CEMI) +61%.AeroCentury (ACY) +59%.Xcel Brands (XELB) +54%.dMY Technology (DMYD) +34%.Performant Financial (PFMT) +33%.Nephros (NEPH) +27%.Nano-X Imaging (NNOX) +26%.Regional Health Properties (RHE) +24%.Leaf Group (LEAF) +21%....
Seekingalpha · 04/05 16:40
Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers
Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%, Benitec Biopharma (BNT...
Seekingalpha · 04/05 15:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of POAI. Analyze the recent business situations of Predictive Oncology Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 28
Institutional Holdings: 625.43K
% Owned: 1.28%
Shares Outstanding: 48.79M
TypeInstitutionsShares
Increased
4
128.13K
New
3
20.38K
Decreased
0
0
Sold Out
2
46.96K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.46%
Healthcare Equipment & Supplies
-0.53%
Key Executives
President/Director
Carl Schwartz
Chief Executive Officer
J. Engle
Chief Financial Officer
Robert Myers
Senior Vice President
David Johnson
Director
Richard Gabriel
Director
H. Gabriel
Director
Daniel Handley
Director
Ricardo Koenigsberger
Director
Timothy Krochuk
Director
Frank Mancuso
Independent Director
Nancy Chung-Welch
Independent Director
Chuck Nuzum
Independent Director
Gregory St.Clair
No Data
About POAI
Predictive Oncology Inc. is focused on applying artificial intelligence (AI) to personalized medicine and drug discovery. It operates through its subsidiaries, Helomics Holding Corporation (Helomics), TumorGenesis Inc., Skyline Europe and Skyline Medical Inc. Helomics applies AI to its data gathered from patient tumors to both personalize cancer therapies for patients and focusses on the development of new-targeted therapies. Helomics’ clinical laboratory improvement amendments (CLIA)-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions. Its TumorGenesis Inc. is engaged in developing approach to tumors in the laboratory. Skyline Medical Inc. markets its STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions.

Webull offers kinds of Predictive Oncology Inc stock information, including NASDAQ:POAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, POAI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading POAI stock methods without spending real money on the virtual paper trading platform.